Beta adrenergic agonist and methods of using the same
AssigneeCuraSen Therapeutics, Inc.
InventorsAnthony P. Ford, Wei Chen, David Scott Carter, Jiaxin Yu
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with an adrenergic receptor. In certain embodiments of the methods disclosed herein, the methods include administering to the subject a compound as disclosed herein and a peripherally acting P-blocker (PABRA).
Claims20
A pharmaceutical composition comprising about 10 pg to 100 mg of a compound having the following structure:
- or a pharmaceutically acceptable salt thereof, as a unit dosage form.
A method of treating a disease associated with an adrenergic receptor by slowing down, lessening symptoms of, and/or halting the progression of the disease in a subject in need thereof comprising administering to the subject a pharmaceutical composition comprising a compound having the following structure:
- or a pharmaceutically acceptable salt thereof, thereby treating the disease in the subject.
Dependencies are inferred from the claim text.